An introduction from
our management

- Chairman's Statement

- Letter from the CEO

o1
Chiesi at a Glance

02
Positive Impacts
and Challenges

- Products and Patients
~ Processes

- Global Value Chain

- Corporate Citizenship

03

Chiesi’s contribution
to the UN Sustainable
Development Goals

04
Annexes
- Impact Report
- Data, Methodology
and GRI Content Index

We want to act as a force for good, promoting a conscious and different way
of doing business which strives to achieve a positive impact on society and
nature by handling resources in a circular way and creating a new harmony and
sustainability. The well-being of all depends on this balance. For us, this is the

only true form of progress.

Our team of professionals is highly motivated and open-minded as our culture
guides us, valuing the diversity of each individual.

The heaktr of our plarel and Ue irhubilanly
degerveg our begl orig.

The specific purposes of
Common Benefit of Chiesi
Farmaceutici

The Articles of Incorporation of Chiesi Farmaceutici Spa include four specific
purposes of common benefit, as well as a general purpose that defines our

profile as a Benefit Company:

(1) Commitment to continuous and sustainable innovation of processes and all
business practices in order to minimise negative impacts and amplify positive
impacts on people, the biosphere and the territory.

(I) Positive impact on people and patients, with the aim of improving their
health, well-being and quality of life.

(Ill) Contribution to the development of the local communities in which the

Company operates.

(IV) Promotion of a conscious and sustainable way of conducting business,

also through collaborative dialogue with stakeholders.

Moreover, the company pursues - together with the economic objectives of an
entrepreneurial activity - general purposes of common benefit and operates in a
responsible, sustainable and transparent manner towards people, communities,
territories and the environment, cultural and social assets and activities, bodies
and associations and other stakeholders.

The following pages deal with the specific purposes of common benefit and for
each of them we have reported:

—the specific objectives, as set out in the Strategic Plan 2018-22

—the reporting of activities and targets compared to 2019

— the activities and targets to be achieved during 2020, to contribute to each

specific purpose of common benefit

113

Annexes
